Contract 36C25620P0044
Fulgent Therapeutics Llc · Department Of Veterans Affairs · October 8, 2019
Fulgent Therapeutics Llc was awarded a federal contract by Department Of Veterans Affairs on October 8, 2019 for $644,000 of work in pharmaceutical preparation manufacturing. Performance is in Houston, TX. It was awarded under full and open competition. The contract has been modified 13 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 11, 2024.
Contract details
- PIID
- 36C25620P0044
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Houston, TX
- First action
- October 8, 2019
- Latest action
- December 11, 2024
Description
GENETICS TESTING DE-OB EXCESS
Modification timeline
-
December 11, 2024Mod P00013$-3.0K
-
April 25, 2024Mod P00012$87.4K
-
April 17, 2024Mod P00011$25.0K
-
January 5, 2024Mod P00010$-15.0K
-
October 1, 2023Mod P00009$162.6K
-
September 6, 2023Mod P00008$0
-
January 6, 2023Mod P00007$-52.2K
-
October 1, 2022Mod P00006$165.9K
-
January 6, 2022Mod P00005$-76.8K
-
November 29, 2021Mod P00004EO14042-LABORATORY TESTING KITS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C25620P0044?
Contract 36C25620P0044 is a federal contract awarded to Fulgent Therapeutics Llc by Department Of Veterans Affairs on October 8, 2019 for $644,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 13 times since the base award.
Who won contract 36C25620P0044?
Fulgent Therapeutics Llc won contract 36C25620P0044 from Department Of Veterans Affairs.
How much is contract 36C25620P0044 worth?
Contract 36C25620P0044 has obligated $644,000 to date, with a total potential value of $889,000 if all options are exercised.